Paula Fraenkel serves as the Executive Director and Global Project Lead for Oncology at AstraZeneca, where she plays a pivotal role in spearheading innovative drug development projects aimed at transforming cancer care. With her extensive background as a physician-scientist, Paula combines her clinical expertise with...
Paula Fraenkel serves as the Executive Director and Global Project Lead for Oncology at AstraZeneca, where she plays a pivotal role in spearheading innovative drug development projects aimed at transforming cancer care. With her extensive background as a physician-scientist, Paula combines her clinical expertise with a robust understanding of translational research, enabling her to bridge the gap between laboratory discoveries and clinical applications. Her leadership is instrumental in guiding multidisciplinary teams through the complexities of oncology drug development, ensuring that promising therapies progress efficiently from preclinical stages to clinical trials.
At AstraZeneca, Paula is currently overseeing several key projects that focus on advancing targeted therapies and immuno-oncology treatments. Her work involves leveraging animal models and clinical research methodologies to evaluate the efficacy and safety of novel compounds, while also fostering collaborations across various departments to enhance research outcomes. Her deep knowledge in hematology and oncology allows her to navigate the intricacies of disease mechanisms, thereby informing strategic decisions that align with the company’s mission to deliver life-changing medicines to patients.
Paula's commitment to medical education and healthcare management further enriches her role, as she actively engages in mentoring the next generation of researchers and clinicians. Her medical degree from Harvard University serves as a foundation for her analytical approach to problem-solving and innovation in the healthcare sector. With a passion for improving patient outcomes, Paula Fraenkel continues to make significant contributions to the field of oncology, driving forward AstraZeneca's vision of pioneering breakthroughs in cancer treatment.
